dr. Scott Ailliet (MD)

CRIG member
Scott Ailliet

PhD fellow – OncoRNAlab, Center for Medical Genetics (UGent)
Specialist in training - clinical biology (KU Leuven)
Principal investigator: prof. Pieter Mestdagh (PhD)


Research focus

A photoelectrochemical singlet oxygen-based platform for the rapid detection of a panel of cancer biomarkers in tissue and liquid biopsies (SOCan). SOCan will contribute to the (early) diagnosis and follow up of cancer via a new disruptive detection platform, i.e. singlet oxygen-based photoelectrochemical detection of cancer biomarkers. Those biomarkers are increasingly discovered and validated, but the detection necessitates rapid, accurate and sensitive devices. To achieve this, the combined use of electrochemical detection with light-triggered sensor technology for the specific and sensitive detection of pre-selected DNA and RNA cancer biomarkers is proposed. The application of this technology on tissue and liquid biopsy samples will be a major contribution to the early detection of cancer. SOCan aligns with the EU Mission on Cancer and will lead to an affordable and sensitive diagnosis of cancer, reducing the time to result which allows faster and specific treatment, and thereby saving lives. 

Contact & links

  • Lab address: Campus UZ Gent, Corneel Heymanslaan 10, entrance 36 (blok B), ground floor, 9000 Ghent, Belgium
  • Scott Ailliet is interested to receive invitations for presentations or talks